1. Home
  2. KNF vs AXSM Comparison

KNF vs AXSM Comparison

Compare KNF & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KNF
  • AXSM
  • Stock Information
  • Founded
  • KNF 1917
  • AXSM 2012
  • Country
  • KNF United States
  • AXSM United States
  • Employees
  • KNF N/A
  • AXSM N/A
  • Industry
  • KNF
  • AXSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • KNF
  • AXSM Health Care
  • Exchange
  • KNF Nasdaq
  • AXSM Nasdaq
  • Market Cap
  • KNF 5.9B
  • AXSM 4.2B
  • IPO Year
  • KNF N/A
  • AXSM 2015
  • Fundamental
  • Price
  • KNF $100.25
  • AXSM $84.60
  • Analyst Decision
  • KNF Strong Buy
  • AXSM Strong Buy
  • Analyst Count
  • KNF 5
  • AXSM 14
  • Target Price
  • KNF $103.75
  • AXSM $125.54
  • AVG Volume (30 Days)
  • KNF 516.6K
  • AXSM 893.5K
  • Earning Date
  • KNF 02-13-2025
  • AXSM 02-18-2025
  • Dividend Yield
  • KNF N/A
  • AXSM N/A
  • EPS Growth
  • KNF 10.75
  • AXSM N/A
  • EPS
  • KNF 3.51
  • AXSM N/A
  • Revenue
  • KNF $2,888,677,000.00
  • AXSM $338,457,000.00
  • Revenue This Year
  • KNF $3.27
  • AXSM $44.77
  • Revenue Next Year
  • KNF $6.33
  • AXSM $67.70
  • P/E Ratio
  • KNF $28.55
  • AXSM N/A
  • Revenue Growth
  • KNF 6.16
  • AXSM 51.47
  • 52 Week Low
  • KNF $61.82
  • AXSM $64.11
  • 52 Week High
  • KNF $108.39
  • AXSM $105.00
  • Technical
  • Relative Strength Index (RSI)
  • KNF 49.53
  • AXSM 43.66
  • Support Level
  • KNF $91.46
  • AXSM $79.19
  • Resistance Level
  • KNF $102.96
  • AXSM $87.53
  • Average True Range (ATR)
  • KNF 3.36
  • AXSM 4.37
  • MACD
  • KNF -0.72
  • AXSM -0.02
  • Stochastic Oscillator
  • KNF 61.60
  • AXSM 61.27

About KNF Knife Riv Holding Co.

Knife River Holding Co formerly Knife River Corp provides construction materials and contracting services throughout the western, central, and southern United States. Knife River produces and delivers aggregates and markets crushed stone, sand, gravel, and related construction materials, including ready-mix concrete, asphalt, and other value-added products. It also distributes cement and asphalt oil. It has more than 1 billion tons of aggregate reserves, 110 ready-mix plants, 50 asphalt plants, and a combined 410,000 tons of liquid asphalt and cement storage. The company also performs integrated contracting services for most types of aggregate-related construction, including roads, freeways, bridges, residential properties, schools, shopping centers, office buildings, and industrial parks.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: